Glen Harbor Capital Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-115
| Closed | -$106K | – | 1354 |
|
|
2019
Q2 | $106K | Buy |
115
+27
| +31% | +$24.9K | ﹤0.01% | 1159 |
|
|
2019
Q1 | $141K | Hold |
88
| – | – | ﹤0.01% | 1080 |
|
|
2018
Q4 | $165K | Hold |
88
| – | – | ﹤0.01% | 1003 |
|
|
2018
Q3 | $208K | Hold |
88
| – | – | ﹤0.01% | 1032 |
|
|
2018
Q2 | $305K | Hold |
88
| – | – | 0.01% | 833 |
|
|
2018
Q1 | $251K | Hold |
88
| – | – | 0.01% | 891 |
|
|
2017
Q4 | $228K | Buy |
88
+31
| +54% | +$80.3K | 0.01% | 931 |
|
|
2017
Q3 | $161K | Buy |
57
+10
| +21% | +$28.2K | ﹤0.01% | 986 |
|
|
2017
Q2 | $110K | Buy |
47
+22
| +88% | +$51.5K | ﹤0.01% | 1064 |
|
|
2017
Q1 | $62K | Buy |
25
+2
| +9% | +$4.96K | ﹤0.01% | 1083 |
|
|
2016
Q4 | $52K | Buy |
+23
| New | +$52K | ﹤0.01% | 1084 |
|